Argan, Inc. AGX
364.29
3.23
0.89%
as of 25 Sep
- Market cap
- $5.1B
- P/E
- 28.3×
Follow AGX
Growth Flags
show if company had growth for consecutive years
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
35.00 | 35.65 | 57.61 | 44.36 |
P/S ratio |
4.63 | 5.19 | 8.98 | 6.73 | |
P/FCF ratio |
14.97 | 11.93 | 19.21 | 14.66 | |
P/Operating CF |
24.55 | 28.43 | 82.48 | 82.52 | |
P/B ratio |
10.09 | 10.60 | 19.75 | 15.79 | |
Price to Tangible BV |
10.85 | 11.32 | 21.06 | 17.02 | |
EV/Sales |
3.83 | 4.24 | 8.04 | 5.87 | |
EV/EBITDA |
28.84 | 29.31 | 53.09 | 37.75 | |
EV/Operating CF |
12.22 | 9.66 | 17.00 | 12.56 | |
EV/FCF |
12.40 | 9.75 | 17.21 | 12.78 | |
Quick Ratio |
1.45 | 1.45 | 1.39 | 1.38 | |
Current Ratio |
1.61 | 1.59 | 1.53 | 1.50 | |
Net Debt/EBITDA |
(21.93) | (18.58) | (21.19) | (17.90) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.01 | 0.93 | 1.00 | 1.04 | |
Operating CF/Net income |
5.61 | 3.50 | 2.46 | 1.82 | |
Capex/Depreciation |
(1.15) | (2.41) | (4.35) | (8.15) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
5.70% | 6.84% | 5.40% | 4.53% | |
Intangible Assets out of Total Assets |
0.03 | 0.02 | 0.02 | 0.03 | |
Share Based Compensation of Revenue |
0.74% | 0.97% | 0.70% | 0.63% | |
Graham Net Nets |
0.09 | 0.08 | 0.04 | 0.05 | |
Graham Number |
77.30 | 86.82 | 94.21 | 102.25 | |
Earnings Yield |
2.86% | 2.81% | 1.74% | 2.25% | |
Free Cash Flow Yield |
6.68% | 8.39% | 5.21% | 6.82% | |
Revenue per Share |
18.16 | 19.03 | 20.84 | 27.37 | |
Operating CF per Share |
12.47 | 12.51 | 8.12 | 6.91 | |
Capex per Share |
(0.04) | (0.09) | (0.17) | (0.37) | |
Free Cash Flow per Share |
12.43 | 12.43 | 7.95 | 6.54 | |
Cash per Share |
52.55 | 64.99 | 69.74 | 73.31 | |
Shareholders Equity per Share |
30.35 | 33.57 | 33.92 | 36.13 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
30.35 | 33.57 | 33.92 | 36.13 | |
Free Cash Flow |
171.91 | 171.13 | 110.95 | 91.72 | |
Working Capital |
377.31 | 421.00 | 421.42 | 440.36 | |
Capital Expenditures |
(0.58) | (1.20) | (2.43) | (5.25) | |
Net Current Asset Value |
366.01 | 408.17 | 403.18 | 424.34 | |
EV/EBIT |
29.31 | 29.73 | 53.79 | 38.21 | |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.01 | |
Net Profit Margin |
12.24% | 18.78% | 15.83% | 13.88% | |
Price to Operating Income |
35.38 | 36.37 | 60.05 | 43.85 | |
| Other line items | |||||
Average Receivables |
151.02 | 154.74 | 118.65 | 179.76 | |
Average Payables |
93.94 | 102.42 | 96.56 | 105.63 | |
Average Assets |
909.87 | 1,011.29 | 1,039.30 | 1,141.84 | |
Average Common Equity |
374.21 | 407.06 | 418.70 | 450.01 |
Columns are period end dates